Li, Xin
Lebeaupin, Cynthia https://orcid.org/0000-0003-1609-5676
Kadianaki, Aikaterini https://orcid.org/0009-0004-4549-2018
Druelle-Cedano, Clementine https://orcid.org/0000-0002-4519-5660
Vesper, Niklas https://orcid.org/0009-0006-8165-0612
Rennert, Charlotte https://orcid.org/0000-0003-2186-2606
Huguet-Pradell, Júlia https://orcid.org/0000-0003-1489-356X
Gomez Ramos, Borja
Fan, Chaofan
Piecyk, Robert Stefan https://orcid.org/0009-0002-1912-4487
Zizmare, Laimdota https://orcid.org/0000-0001-7208-3659
Ramadori, Pierluigi https://orcid.org/0000-0001-6581-9648
Li, Luqing
Frick, Lukas
Qiu, Menjie https://orcid.org/0000-0002-0342-3661
Zhang, Cangang
Martins Nascentes Melo, Luiza https://orcid.org/0000-0002-5980-5220
Ranvir, Vikas Prakash https://orcid.org/0000-0002-0437-6908
Shen, Peng https://orcid.org/0009-0001-5723-8744
Hanselmann, Johannes
Kosla, Jan
Fernández-Vaquero, Mirian https://orcid.org/0000-0002-2781-5643
Vucur, Mihael https://orcid.org/0000-0003-4078-1668
Baskaran, Praveen
Bao, Xuanwen
Coleman, Olivia I. https://orcid.org/0000-0002-4075-7820
Tang, Yingyue
Cetin, Miray https://orcid.org/0009-0001-7711-0211
Chen, Zhouji
Jang, Insook https://orcid.org/0000-0001-7567-3849
Del Prete, Stefania https://orcid.org/0000-0002-1806-1819
Rahbari, Mohammad https://orcid.org/0000-0003-1133-2134
Zhang, Peng
Pham, Timothy V.
Hou, Yushan
Sun, Aihua https://orcid.org/0000-0001-7931-6662
Gu, Li https://orcid.org/0000-0001-5812-9024
Kim, Laura C. https://orcid.org/0000-0001-8229-2745
Rothermel, Ulrike
Heide, Danijela
Ali, Adnan
Gallage, Suchira https://orcid.org/0000-0002-1956-3597
Talvard-Balland, Nana https://orcid.org/0000-0001-8590-6351
Piqué-Gili, Marta
Gris-Oliver, Albert https://orcid.org/0000-0003-1802-9541
Bevilacqua, Alessio https://orcid.org/0000-0001-7009-4362
Schlicker, Lisa
Duffey, Alec
Unger, Kristian
Szydlowska, Marta
Hetzer, Jenny
Odom, Duncan T.
Machauer, Tim
Bucci, Daniele
Sant, Pooja https://orcid.org/0000-0001-9301-3211
Lee, Jun-Hoe https://orcid.org/0000-0002-6331-3472
Rösler, Jonas
Meckelmann, Sven W.
Schreck, Johannes
Murray, Sue
Simon, M. Celeste https://orcid.org/0000-0001-9106-447X
Nahnsen, Sven https://orcid.org/0000-0002-4375-0691
Schulze, Almut https://orcid.org/0000-0002-8199-6422
Ho, Ping-Chih https://orcid.org/0000-0003-3078-3774
Jugold, Manfred
Breuhahn, Kai
Mallm, Jan-Philipp https://orcid.org/0000-0002-7059-4030
Schirmacher, Peter
Roth, Susanne
Rahbari, Nuh
Tschaharganeh, Darjus F. https://orcid.org/0000-0002-2369-5138
Roessler, Stephanie https://orcid.org/0000-0002-5333-5942
Goeppert, Benjamin
Bengsch, Bertram https://orcid.org/0000-0003-2552-740X
Andrieux, Geoffroy https://orcid.org/0000-0002-5389-9481
Boerries, Melanie https://orcid.org/0000-0002-3670-0602
Malek, Nisar P. https://orcid.org/0000-0002-9916-4608
Prinz, Marco https://orcid.org/0000-0002-0349-1955
Weber, Achim https://orcid.org/0000-0003-0073-3637
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
Tamayo, Pablo
Bronsert, Peter https://orcid.org/0000-0001-8558-0347
Kurowski, Konrad https://orcid.org/0009-0009-0448-7999
Thimme, Robert https://orcid.org/0000-0003-1417-4135
Yuan, Detian https://orcid.org/0000-0003-1855-4768
Carretero, Rafael
Luedde, Tom https://orcid.org/0000-0002-6288-8821
Pinyol, Roser https://orcid.org/0000-0002-0288-6314
Hartmann, Felix J. https://orcid.org/0000-0002-4174-2276
Karin, Michael https://orcid.org/0000-0002-2758-6473
Tasdogan, Alpaslan https://orcid.org/0000-0003-2543-852X
Trautwein, Christoph https://orcid.org/0000-0003-4672-6395
Mall, Moritz https://orcid.org/0000-0002-1278-2594
Hofmann, Maike https://orcid.org/0000-0001-8410-8833
Llovet, Josep M.
Haller, Dirk https://orcid.org/0000-0002-6977-4085
Kaufman, Randal J. https://orcid.org/0000-0003-4277-316X
Heikenwälder, Mathias https://orcid.org/0000-0002-3135-2274
Article History
Received: 5 October 2023
Accepted: 10 December 2025
First Online: 4 February 2026
Competing interests
: J.M.L. has received research support from Bayer Pharmaceuticals, Eisai, Bristol-Myers Squibb and Ipsen. He has also received consultancy fees from Bayer HealthCare Pharmaceuticals, Eisai, Merck, Bristol-Myers Squibb, Eli Lilly, Roche, Genentech, Ipsen, Glycotest, AstraZeneca, Omega Therapeutics, Mina Alpha, Boston Scientific, Exelixis, Bluejay, Abbvie, Moderna and Captor Therapeutics. The ASO compounds targeted to mouse Atf6 were provided to SBP through a material transfer agreement with Ionis Pharmaceuticals. R.J.K. is consulting with Metagenomi Phar. C.L. is currently an employee at Pfizer. L.Z. is currently an employee at Dr. Falk Pharma. The other authors declare no competing interests.